Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma

被引：33

作者：

Valcamonico, Francesca ^{[1
]}

Ferrari, Vittorio ^{[1
]}

Amoroso, Vito ^{[1
]}

Rangoni, Giovanni ^{[1
]}

Simoncini, Edda ^{[1
]}

Marpicati, Patrizia ^{[1
]}

Vassalli, Lucia ^{[1
]}

Grisanti, Salvatore ^{[1
]}

Marini, Giovanni ^{[1
]}

机构：

[1] Spedali Civili Brescia, Dept Med Oncol, Brescia, Italy

来源：

JOURNAL OF NEURO-ONCOLOGY | 2009年 / 91卷 / 01期

关键词：

Advanced renal cell carcinoma; Sorafenib; Brain metastases; ANTITUMOR-ACTIVITY; TRIAL;

D O I：

10.1007/s11060-008-9676-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We report the case of a 75-year old woman who received sorafenib (Nexavar (R), Bayer Pharmaceuticals Corporation, West Haven, CT) for a CNS relapse of clear cell renal cell carcinoma. After four months of sorafenib treatment, a brain magnetic resonance imaging showed 95%-volumetric regression of cerebral metastasis. To the best of our knowledge, this is the first almost complete resolution of brain metastases in renal cell carcinoma treated with sorafenib that has been described.

引用

页码：47 / 50

页数：4

共 50 条

[1] Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma
Francesca Valcamonico
Vittorio Ferrari
Vito Amoroso
Giovanni Rangoni
Edda Simoncini
Patrizia Marpicati
Lucia Vassalli
Salvatore Grisanti
Giovanni Marini
Journal of Neuro-Oncology, 2009, 91 : 47 - 50
[2] Long-lasting tumour response to sorafenib therapy in advanced hepatocellular carcinoma
Kirstein, M. M.
Schweitzer, N.
Schmidt, S.
Kloepper, A.
Ringe, K. I.
Lehmann, U.
Manns, M. P.
Wedemeyer, H.
Vogel, A.
ACTA GASTRO-ENTEROLOGICA BELGICA, 2014, 77 (04): : 386 - 388
[3] A LONG-LASTING RESPONSE TO SORAFENIB TREATMENT IN AN ADVANCED HEPATOCELLULAR CARCINOMA PATIENT
Di Lorenzo, G.
Imbimbo, M.
Leopardo, D.
Marciano, R.
Federico, P.
Buonerba, C.
Salvatore, B.
Marinelli, A.
Palmieri, G.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2010, 23 (03) : 951 - 954
[4] Rapid long-lasting biochemical and radiological response to sorafenib in a case of advanced hepatocellular carcinoma
Gerardi, Assunta Maria Teresa
Stoppino, Luca Pio
Liso, Arcangelo
Macarini, Luca
Landriscina, Matteo
ONCOLOGY LETTERS, 2013, 5 (03) : 975 - 977
[5] Optimized management of advanced hepatocellular carcinoma:Four long-lasting responses to sorafenib
Giovanni Abbadessa
Lorenza Rimassa
Tiziana Pressiani
Cynthia Carrillo-Infante
Emanuele Cucchi
Armando Santoro
World Journal of Gastroenterology, 2011, 17 (19) : 2450 - 2453
[6] Optimized management of advanced hepatocellular carcinoma: Four long-lasting responses to sorafenib
Abbadessa, Giovanni
Rimassa, Lorenza
Pressiani, Tiziana
Carrillo-Infante, Cynthia
Cucchi, Emanuele
Santoro, Armando
WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (19) : 2450 - 2453
[7] Long-lasting response with metronomic capecitabine in advanced hepatocellular carcinoma
Ballardini, Pierluigi
Marri, Ivan
Margutti, Guido
Aliberti, Camillo
Benea, Giorgio
Manfredini, Roberto
TUMORI JOURNAL, 2010, 96 (05): : 768 - 770
[8] Sorafenib for the management of advanced renal cell carcinoma
Escudier, Bernard
EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (06) : 825 - 836
[9] Sorafenib in renal cell carcinoma
Angel Arranz, Jose
Angel Climent, Miguel
Luis Gonzalez-Larriba, Jose
Leon, Luis
Pablo Maroto, Jose
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 80 (02) : 314 - 322
[10] Downsizing a Thrombus of Advanced Renal Cell Carcinoma in a Presurgical Setting with Sorafenib
Takeda, Hirokazu
Nakano, Yojiro
Kashiwagi, Yuhta
Yoshino, Yasushi
Gotoh, Momokazu
UROLOGIA INTERNATIONALIS, 2012, 88 (02) : 235 - 237

← 1 2 3 4 5 →